SC, C., YT, C., LF, C., CH, T., CY, C., CP, S., . . . SW, L. (2026). Development of a novel hemophilia A mouse model to study emicizumab and factor VIII inhibitor risk. Blood advances, 10(9), 3118. https://doi.org/10.1182/bloodadvances.2025018691
Chicago Style (17th ed.) CitationSC, Chou, et al. "Development of a Novel Hemophilia A Mouse Model to Study Emicizumab and Factor VIII Inhibitor Risk." Blood Advances 10, no. 9 (2026): 3118. https://doi.org/10.1182/bloodadvances.2025018691.
MLA (9th ed.) CitationSC, Chou, et al. "Development of a Novel Hemophilia A Mouse Model to Study Emicizumab and Factor VIII Inhibitor Risk." Blood Advances, vol. 10, no. 9, 2026, p. 3118, https://doi.org/10.1182/bloodadvances.2025018691.
Warning: These citations may not always be 100% accurate.
